Connection
David Schwartz to Enterobacteriaceae Infections
This is a "connection" page, showing publications David Schwartz has written about Enterobacteriaceae Infections.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.382 |
|
|
|
-
Dickstein Y, Solter E, Schwartz D, Nutman A, Harevrich I, Wulffhart L, Carmeli Y, Schwaber MJ. The Israeli national policy for discontinuation of isolation of carbapenem-resistant Enterobacterales carriers by carbapenemase type: a retrospective cohort study. Clin Microbiol Infect. 2021 Oct; 27(10):1518.e1-1518.e3.
Score: 0.175
-
Henao-MartÃnez AF, Agler AH, LaFlamme D, Schwartz DA, Yang IV. Polymorphisms in the SUFU gene are associated with organ injury protection and sepsis severity in patients with Enterobacteriacea bacteremia. Infect Genet Evol. 2013 Jun; 16:386-91.
Score: 0.099
-
Adler A, Navon-Venezia S, Moran-Gilad J, Marcos E, Schwartz D, Carmeli Y. Laboratory and clinical evaluation of screening agar plates for detection of carbapenem-resistant Enterobacteriaceae from surveillance rectal swabs. J Clin Microbiol. 2011 Jun; 49(6):2239-42.
Score: 0.086
-
Moran Gilad J, Carmeli Y, Schwartz D, Navon-Venezia S. Laboratory evaluation of the CHROMagar KPC medium for identification of carbapenem-nonsusceptible Enterobacteriaceae. Diagn Microbiol Infect Dis. 2011 Aug; 70(4):565-7.
Score: 0.022